CMR Naviscan Corporation

We are a global medical technology company committed to providing peace of mind to patients and physicians alike through the use of MBI and PET as secondary screening and diagnostic tools. Both the LumaGEM ® Molecular Breast Imaging (MBI) system and the Solo II™ High Resolution Breast PET system have advanced photonics and image processing that provide images with a resolution as small as 1.6 mm. The high sensitivity and specificity of our products provide highly accurate imaging information that enable physicians to detect and treat breast cancer. Our Stereo Navigator is the first FDA-cleared commercially available breast PET guided biopsy accessory. CMR Molecular Imaging is a unit of CMR Naviscan Corporation.